Inlicid MPS Uses

Is this medication very expensive?
sponsored

What is Inlicid MPS?

Inlicid MPS is used as a dietary supplement for individuals who are deficient in Inlicid MPS. Although a balanced diet usually supplies all the Inlicid MPS a person needs, Inlicid MPS supplements may be needed by patients who have lost Inlicid MPS because of illness or treatment with certain medicines.

Lack of Inlicid MPS may lead to irritability, muscle weakness, and irregular heartbeat.

Injectable Inlicid MPS is given only by or under the supervision of a health care professional. Some oral Inlicid MPS preparations are available only with a prescription. Others are available without a prescription.

Inlicid MPS indications

An indication is a term used for the list of condition or symptom or illness for which the medicine is prescribed or used by the patient. For example, acetaminophen or paracetamol is used for fever by the patient, or the doctor prescribes it for a headache or body pains. Now fever, headache and body pains are the indications of paracetamol. A patient should be aware of the indications of medications used for common conditions because they can be taken over the counter in the pharmacy meaning without prescription by the Physician.
sponsored

peptic ulcer, gastritis, dyspepsia

How should I use Inlicid MPS?

Use Inlicid MPS as directed by your doctor. Check the label on the medicine for exact dosing instructions.

Ask your health care provider any questions you may have about how to use Inlicid MPS.

Uses of Inlicid MPS in details

There are specific as well as general uses of a drug or medicine. A medicine can be used to prevent a disease, treat a disease over a period or cure a disease. It can also be used to treat the particular symptom of the disease. The drug use depends on the form the patient takes it. It may be more useful in injection form or sometimes in tablet form. The drug can be used for a single troubling symptom or a life-threatening condition. While some medications can be stopped after few days, some drugs need to be continued for prolonged period to get the benefit from it.

This medication is a mineral supplement used to prevent and treat low amounts of Inlicid MPS in the blood. Inlicid MPS is very important for the normal functioning of cells, nerves, muscles, bones, and the heart. Usually, a well-balanced diet provides normal blood levels of Inlicid MPS. However, certain situations cause your body to lose Inlicid MPS faster than you can replace it from your diet. These situations include treatment with "water pills" (diuretics such as furosemide, hydrochlorothiazide), a poor diet, alcoholism, or other medical conditions (e.g., severe diarrhea/vomiting, stomach/intestinal absorption problems, poorly controlled diabetes).

How to use Inlicid MPS (oxide/AA chelate)

Take this product by mouth as directed. Follow all directions on the product package. If you are uncertain about any of the information, consult your doctor or pharmacist.

It is best to take Inlicid MPS supplements with a meal to reduce stomach upset and diarrhea unless otherwise directed by the product instructions or your doctor.

Take each dose with a full glass (8 ounces or 240 milliliters) of water unless your doctor directs you otherwise. Swallow extended-release capsules and delayed-release/enteric coated tablets or capsules whole. Do not crush or chew extended-release or delayed-release/enteric coated capsules or tablets. Doing so can release all of the drug at once, increasing the risk of side effects. Also, do not split extended-release tablets unless they have a score line and your doctor or pharmacist tells you to do so. Swallow the whole or split tablet without crushing or chewing.

If you are using a liquid product, use a medication measuring device to carefully measure the dose. Do not use a household spoon because you may not get the correct dose. If you are using a suspension, shake the bottle well before each dose.

Take this medication regularly in order to get the most benefit from it. Remember to take it at the same time(s) each day. Dosage is based on your medical condition and response to treatment. Do not increase your dose or take it more often than directed on the product package or by your doctor. Too much Inlicid MPS in the blood can cause serious side effects.

Tell your doctor if symptoms of low Inlicid MPS blood levels (e.g., muscle cramps, tiredness, irritability, depression) persist or worsen. If you think you may have a serious medical problem, seek immediate medical attention.

Inlicid MPS dosage

sponsored

Usual Adult Dose for Hypomagnesemia

500 to 1000 mg Inlicid MPS gluconate (27 to 54 mg elemental Inlicid MPS) orally 3 times a day.

Usual Adult Dose for Dietary Supplement

500 to 1000 mg Inlicid MPS gluconate (27 to 54 mg elemental Inlicid MPS) orally once a day.

Usual Pediatric Dose for Hypomagnesemia

10 to 20 mg/kg of elemental Inlicid MPS per dose orally 4 times a day. Use Inlicid MPS gluconate oral liquid preparations for more accurate measurement of dose.

Renal Dose Adjustments

Do not use without physician supervision in patients with renal impairment due to increased risk of hypermagnesemia. The use of Inlicid MPS salts are generally contraindicated in patients with severe renal dysfunction.

Liver Dose Adjustments

Data not available

Dose Adjustments

May increase by 500 to 1,000 mg/day (27 to 54 mg elemental Inlicid MPS) in order to achieve a normal serum Inlicid MPS level. Daily doses > 1,000 mg (54 mg elemental Inlicid MPS) should be given in 2 to 3 divided doses.

Precautions

Because Inlicid MPS is primarily eliminated by the kidney, there is significant risk of hypermagnesemia in patients with renal dysfunction.

Dialysis

Data not available; however, use of Inlicid MPS salts is generally contraindicated in renal failure.

Other Comments

Inlicid MPS supplements are often used with "low normal" serum Inlicid MPS levels in patients predisposed to hypomagnesemia (e.g., patients on diuretics).

Inlicid MPS interactions

See also:
What other drugs will affect Inlicid MPS?

sponsored

Alfacalcidol: May increase the serum concentration of Inlicid MPS Salts. Consider therapy modification

Alpha-Lipoic Acid: Inlicid MPS Salts may decrease the absorption of Alpha-Lipoic Acid. Alpha-Lipoic Acid may decrease the absorption of Inlicid MPS Salts. Consider therapy modification

Baloxavir Marboxil: Polyvalent Cation Containing Products may decrease the serum concentration of Baloxavir Marboxil. Avoid combination

Bictegravir: Polyvalent Cation Containing Products may decrease the serum concentration of Bictegravir. Management: Administer bictegravir under fasting conditions at least 2 hours before or 6 hours after polyvalent cation containing products. Coadministration of bictegravir with or 2 hours after most polyvalent cation products is not recommended. Consider therapy modification

Bisphosphonate Derivatives: Polyvalent Cation Containing Products may decrease the serum concentration of Bisphosphonate Derivatives. Management: Avoid administration of oral medications containing polyvalent cations within: 2 hours before or after tiludronate/clodronate/etidronate; 60 minutes after oral ibandronate; or 30 minutes after alendronate/risedronate. Exceptions: Pamidronate; Zoledronic Acid. Consider therapy modification

Calcitriol (Systemic): May increase the serum concentration of Inlicid MPS Salts. Management: Consider using a non-Inlicid MPS-containing antacid or phosphate-binding product in patients also receiving calcitriol. If Inlicid MPS-containing products must be used with calcitriol, serum Inlicid MPS concentrations should be monitored closely. Consider therapy modification

Calcium Channel Blockers: May enhance the adverse/toxic effect of Inlicid MPS Salts. Inlicid MPS Salts may enhance the hypotensive effect of Calcium Channel Blockers. Monitor therapy

Deferiprone: Polyvalent Cation Containing Products may decrease the serum concentration of Deferiprone. Management: Separate administration of deferiprone and oral medications or supplements that contain polyvalent cations by at least 4 hours. Consider therapy modification

Dolutegravir: Inlicid MPS Salts may decrease the serum concentration of Dolutegravir. Management: Administer dolutegravir at least 2 hours before or 6 hours after oral Inlicid MPS salts. Administer the dolutegravir/rilpivirine combination product at least 4 hours before or 6 hours after oral Inlicid MPS salts. Consider therapy modification

Doxercalciferol: May enhance the hypermagnesemic effect of Inlicid MPS Salts. Management: Consider using a non-Inlicid MPS-containing antacid or phosphate-binding product in patients also receiving doxercalciferol. If Inlicid MPS-containing products must be used with doxercalciferol, serum Inlicid MPS concentrations should be monitored closely. Consider therapy modification

Eltrombopag: Polyvalent Cation Containing Products may decrease the serum concentration of Eltrombopag. Management: Administer eltrombopag at least 2 hours before or 4 hours after oral administration of any polyvalent cation containing product. Consider therapy modification

Elvitegravir: Polyvalent Cation Containing Products may decrease the serum concentration of Elvitegravir. Management: Administer elvitegravir 2 hours before or 6 hours after the administration of polyvalent cation containing products. Consider therapy modification

Gabapentin: Inlicid MPS Salts may enhance the CNS depressant effect of Gabapentin. Specifically, high dose intravenous/epidural Inlicid MPS sulfate may enhance the CNS depressant effects of gabapentin. Inlicid MPS Salts may decrease the serum concentration of Gabapentin. Management: Administer gabapentin at least 2 hours after use of a Inlicid MPS-containing antacid. Monitor patients closely for evidence of reduced response to gabapentin therapy. Monitor for CNS depression if high dose IV/epidural Inlicid MPS sulfate is used. Consider therapy modification

Levothyroxine: Inlicid MPS Salts may decrease the serum concentration of Levothyroxine. Management: Separate administration of oral levothyroxine and oral Inlicid MPS salts by at least 4 hours. Consider therapy modification

Multivitamins/Fluoride (with ADE): Inlicid MPS Salts may decrease the serum concentration of Multivitamins/Fluoride (with ADE). Specifically, Inlicid MPS salts may decrease fluoride absorption. Management: To avoid this potential interaction separate the administration of Inlicid MPS salts from administration of a fluoride-containing product by at least 1 hour. Consider therapy modification

Mycophenolate: Inlicid MPS Salts may decrease the serum concentration of Mycophenolate. Management: Separate doses of mycophenolate and oral Inlicid MPS salts. Monitor for reduced effects of mycophenolate if taken concomitant with oral Inlicid MPS salts. Consider therapy modification

Neuromuscular-Blocking Agents: Inlicid MPS Salts may enhance the neuromuscular-blocking effect of Neuromuscular-Blocking Agents. Monitor therapy

PenicillAMINE: Polyvalent Cation Containing Products may decrease the serum concentration of PenicillAMINE. Management: Separate the administration of penicillamine and oral polyvalent cation containing products by at least 1 hour. Consider therapy modification

Phosphate Supplements: Inlicid MPS Salts may decrease the serum concentration of Phosphate Supplements. Management: Administer oral phosphate supplements as far apart from the administration of an oral Inlicid MPS salt as possible to minimize the significance of this interaction. Exceptions: Sodium Glycerophosphate Pentahydrate. Consider therapy modification

Quinolones: Inlicid MPS Salts may decrease the serum concentration of Quinolones. Management: Administer oral quinolones several hours before (4 h for moxi/pe/spar-, 2 h for others) or after (8 h for moxi-, 6 h for cipro/dela-, 4 h for lome/pe-, 3 h for gemi-, and 2 h for levo-, nor-, or ofloxacin or nalidixic acid) oral Inlicid MPS salts. Exceptions: LevoFLOXacin (Oral Inhalation). Consider therapy modification

Raltegravir: Inlicid MPS Salts may decrease the serum concentration of Raltegravir. Management: Avoid the use of oral / enteral Inlicid MPS salts with raltegravir. No dose separation schedule has been established that adequately reduces the magnitude of interaction. Avoid combination

Tetracyclines: Inlicid MPS Salts may decrease the absorption of Tetracyclines. Only applicable to oral preparations of each agent. Management: Avoid coadministration of oral Inlicid MPS salts and oral tetracyclines. If coadministration cannot be avoided, administer oral Inlicid MPS at least 2 hours before, or 4 hours after, oral tetracyclines. Monitor for decreased tetracycline therapeutic effects. Exceptions: Eravacycline. Consider therapy modification

Trientine: Polyvalent Cation Containing Products may decrease the serum concentration of Trientine. Management: Avoid concomitant administration of trientine and oral products that contain polyvalent cations. If oral iron supplements are required, separate the administration by 2 hours. If other oral polyvalent cations are needed, separate administration by 1 hour. Consider therapy modification

Inlicid MPS side effects

See also:
What are the possible side effects of Inlicid MPS?

sponsored

Diarrhoea and bowel discomfort, due to the release of carbon dioxide caused by both Inlicid MPS carbonate and sodium bicarbonate.

Excessive administration of Inlicid MPS leads to the development of hypermagnesaemia, especially in renal insufficiency. Symptoms of hypermagnesaemia may include flushing of the skin, thirst, hypotension due to peripheral vasodilation, drowsiness, confusion, loss of tendon reflexes due to neuromuscular blockade, muscle weakness, respiratory depression, cardiac arrhythmias, coma, and cardiac arrest. Inlicid MPS carbonate and Inlicid MPS trisilicate may interfere with the absorption of other medicines when taken concomitantly. Administration of sodium bicarbonate by mouth can cause stomach cramps and flatulence.

Excessive administration of sodium bicarbonate may lead to metabolic alkalosis, especially in patients with impaired renal function. Symptoms may include shortness of breath, muscle weakness (associated with potassium depletion), and mental disturbances such as restlessness, convulsions, and coma. Muscle hypertonicity, twitching, and tetany may develop especially in hypocalcaemic patients due to increased protein binding and renal reabsorption of calcium. Excessive doses may also lead to sodium overloading and hyperosmolality. Sodium excess may result in hypernatraemia, a rise in extracellular concentration or in too much sodium and water in the body without change in extracellular concentration.

Retention of sodium leads to the accumulation of extracellular fluid (oedema) which may affect the cerebral, pulmonary or peripheral circulations.

Inlicid MPS contraindications

See also:
What is the most important information I should know about Inlicid MPS?

Sensitivity to any of the ingredients; patients with renal impairment and acute dehydration.

Active ingredient matches for Inlicid MPS:

Magnesium Hydroxide (Milk of Magnesia)


Unit description / dosage (Manufacturer)Price, USD
Inlicid MPS 170 ml Suspension$ 0.02

List of Inlicid MPS substitutes (brand and generic names):

Gastromax O 170 ml Suspension (Elder Pharmaceuticals Ltd.)$ 0.03
Gelpec MPS 170 ml Gel (Modern Pharmaceuticals)$ 0.02
Geltec Gel 170 ml Syrup (Dutech Remedies (I) Pvt. Ltd.)$ 0.04
Gelucaine 170 ml Suspension (The Pharmed Research Lab Pvt Ltd)$ 0.03
Gigel 170 ml Gel (Prayas Pharmaceuticals)$ 0.01
HC Gel 200 ml Gel (Health Care Formulations Pvt. Ltd.)$ 0.02
HC Gel 100 ml Gel (Health Care Formulations Pvt. Ltd.)$ 0.02
HC REX 200 ml Gel (Health Care Formulations Pvt. Ltd.)$ 0.02
Hegel MPS Syrup (Health Guard (India) Pvt. Ltd.)$ 0.02
Hydralgel MPS 250+250+50 Tablet (Adcco Limited.)$ 0.01
Icycool 200 ml Syrup (Injecto Capta Pvt. Ltd.)$ 0.02
Intacid MPS 170 ml Syrup (Intas Laboratories Pvt Ltd)$ 0.05
Intacid MPS 60 ml Syrup (Intas Laboratories Pvt Ltd)$ 0.06
Intacid MPS Tablet (Intas Laboratories Pvt Ltd)$ 0.01
Neutrogel 170 ml Suspension (Beckcem Drugs International (P) Ltd)$ 0.02
Nokcid MPS 170 ml Syrup (Ambition Pharma Pvt. Ltd.)$ 0.02
Nomorcid MPS 170 ml Suspension (Acto Pharmaceuticals Laboratories)$ 0.02
Normacid 170 ml Gel (Saga Laboratories)$ 0.04
Nucid Gel 170 ml Nuclear Pharma Syrup (Nuclear Pharmaceuticals)$ 0.02
Nucid Gel 170 ml Suspension (Nuclear Pharmaceuticals)$ 0.00
Oltacal Tablet (Altar Healthcare (P) Ltd.)$ 0.04
Orcid 170 ml Suspension (Oirpil Biotech)$ 0.02
Oxecain Gel 200 ml Suspension (Saksham Pharmaceuticals (India) Limited)$ 0.03
Oxycane 170 ml Gel (Invision Medi Sciences)$ 0.05
Sanzyme DS Tablet (Uni-Sankyo Ltd.)$ 0.01
Silocid MPS 170 ml Suspension (Suzikem Drugs Pvt. Ltd.)$ 0.02
Simeco Gel 200 ml Gel (Wyeth Ltd.)$ 0.01
Stgel Mint 170 ml Suspension (ST Sharda Lifesciences)$ 0.06
Stomacid MPS 170 ml Syrup (Pramukh Swami Pharma Ltd.)$ 0.02
Sugel 200 ml Syrup (Winsun Laboratories)$ 0.05
Synogel 100 ml Gel (Synokem Pharmaceuticals Ltd)$ 0.03
Ticid 200 ml Suspension (Tunic Healthcare)$ 0.01
Tisbi 170 ml Syrup (Proteger India)$ 0.04
UD Alusil 200+300+25 Tablet (Union Drug Company Ltd)$ 0.00
Ulcid Tablet (Acron Pharmaceuticals)$ 0.01
Veecain 170 ml Syrup (Vsaar Pharma)$ 0.03
Visco Tablet (Aristo Pharmaceuticals Pvt Ltd.)$ 0.01
VISCO TABLET 1 strip / 10 tablets each (Aristo Pharmaceuticals Pvt Ltd.)$ 0.10
Zancid 170 ml Suspension (Jarson Pharmaceuticals)$ 0.02
Zocid Gel 170 ml Gel (Zota Healthcare Pvt. Ltd.)$ 0.02

Reviews

The results of a survey conducted on ndrugs.com for Inlicid MPS are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Inlicid MPS. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.

User reports

Consumer reported useful

No survey data has been collected yet


Consumer reported price estimates

No survey data has been collected yet


Consumer reported time for results

No survey data has been collected yet


Consumer reported age

No survey data has been collected yet


Consumer reviews


There are no reviews yet. Be the first to write one!


Your name: 
Email: 
Spam protection:  < Type 19 here

Information checked by Dr. Sachin Kumar, MD Pharmacology

| Privacy Policy
This site does not supply any medicines. It contains prices for information purposes only.
© 2003 - 2022 ndrugs.com All Rights Reserved